Cencora, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cencora, Inc. on August 1, 2024, with the earliest event reported on August 1, 2024. The filing details a material definitive agreement and other events involving a share repurchase and a Rule 144 sale by a significant stockholder.
Key Financial Metrics and Transaction Details
- Share Repurchase: Cencora agreed to repurchase 1,039,242 shares of common stock from Walgreens Boots Alliance Holdings LLC.
- Transaction Value: The aggregate price paid for the repurchase was approximately $250 million.
- Rule 144 Sale: The Selling Stockholder sold 3,398,929 shares of common stock under Rule 144.
- Post-Transaction Ownership: Following the sale and repurchase, the Selling Stockholder owns 19,980,000 shares, representing approximately 10.2% of the total outstanding shares.
- Outstanding Shares: Based on July 26, 2024 data, there were 197,046,826 shares outstanding prior to the repurchase. Post-repurchase, the total outstanding shares are 196,007,584.
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity metrics as this is a transaction-specific report rather than a periodic financial statement.
Material Changes
The primary material change is the reduction in the company's outstanding share count by 1,039,242 shares due to the treasury stock repurchase. Additionally, the Selling Stockholder's position was adjusted through a combination of a sale and a repurchase, resulting in a net reduction of their holdings while maintaining a significant ownership stake of approximately 10.2%.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or new risk factors. The transaction was executed under the Company's existing share repurchase program. The repurchased shares will be held in treasury.
Key Facts for Investor Verification
- Verify the exact price per share paid, which was tied to the price of the concurrent Rule 144 sale by the Selling Stockholder.
- Confirm the impact of the $250 million cash outflow on the company's current liquidity position.
- Review the full text of the Share Repurchase Agreement filed as Exhibit 10.1 for specific terms and conditions.
- Monitor the Selling Stockholder's remaining 10.2% stake for potential future sales or strategic implications.